6-Pyruvoyl-tetrahydropterin synthase, which catalyzes the first step in the conversion of 7,s-dihydroneopterin triphosphate to tetrahydrobiopterin, was purified approximately 140,000-fold to apparent homogeneity from human liver. The molecular mass of the enzyme is estimated to be 83 kDa. 7,X-Dihydroneopterin triphosphate was a substrate of the enzyme in the presence of Mg2+, and the pH optimum of the reaction was 7.5 in Tris HCI buffer. The K, value for 7,fLdihydroneopterin triphosphate was 10 pM. The product of this enzymatic reaction was the presumed intermediate 6-pyruvoyl-tetrahydropterin. This latter compound was converted to tetrahydrobiopterin in the presence of NADPH and partially purified sepiapterin reductase from human liver. The conditions and the effect of N-acetylserotonin on this reaction, and on the formation of the intermediates 6-(1 '-hydroxy-2'-oxopropyl)-tetrahydropterin and 6-( 1'0x0-2'-hydroxypropy1)-tetrahydropterin have been studied.
Scheme 1. Proposedpathway for the biosynthesis of tetrahydrobiopterin from dihydroneopterin triphosphate in human liver. The pathway is shown as to proceed from NHlTP (I) to BH4 (7) via alternative (and equivalent) pathways and through the key intermediate 6-pyruvoyltetrahydropterin (PPH,, 4). The structure of this latter intermediate has not yet been proven directly; the compound might also exist in a hydrated or equivalent form. The two first steps in the sequence are catalyzed by a single enzyme, 'PPH4-synthase' ('PPH4S'). In this enzyme the same active center base (B -) is shown to catalyze the abstraction as a proton of both the 1'-H (+), as well as the 2'-H (---+) of the side chain. The enzymes which catalyze the two-step reduction of PPHL (4) to BH4 (7) are 'PPH4 reductase' and sepiapterin reductase (SR), respectively. The sequence of the two steps, i.e. whether reduction occurs first at C-I ' or at C-2', to form intermediates 5 or 6, has not yet been determined tion of NH2TP to BH4 has not yet been fully elucidated. Only the structures of GTP, NH2TP (I), and BH4 (7) have been established beyond doubt. Earlier reports claimed that the biosynthetic pathway of BH4 involved sepiapterin as an intermediate and that this was converted by sepiapterin reductase (EC 1.1.1.153) to BH2. The last reaction in the biosynthetic pathway of BH4 was proposed to be the reduction of BH2 to BH4 by dihydrofolate reductase (EC 1.5.1.3) However, Duch et al. [20] reported as a new important finding, that BH4 biosynthesis was not inhibited by methotrexate, a potent dihydrofolate reductase inhibitor, and they suggested that BH4 biosynthesis might proceed via tetrahydropterin intermediates [20] . All recently published results [21- 311 are indeed consistent with this. It is generally accepted that NHzTP (1) is converted to PPH4 (4) in the presence of Mgz+ by the heat-stable 'Enzyme A' or 'sepiapterin synthase A' from D . melanogaster [14, 22, 261 , 'fraction AT from chicken kidney [15] , and 'SSE-1' [32] or 'dyspropterin synthetase' from silkworm larvae [30] . Our group has also reported studies on the occurrence and purification of a similar enzyme, the 'phosphate-eliminating enzyme', from human liver [lo, 24, 28 , 331 and recently we have reported the purification of the enzyme to apparent homogeneity [34] .
In the present paper we describe in detail the purification and some properties of PPH4S from human liver, and we report on experiments involving the conversion of PPH4 (4) 1191.
to BH4 (7).
EXPERIMENTAL PROCEDURES

Materials
Human liver was obtained from traffic accident victims; it was frozen at -70°C within 60 min after death. BH4 and sepiapterin were purchased from Dr. B. Schircks Laboratories (Buechstrasse 17a, 8645 Jona, Switzerland). NHzTP was prepared enzymatically from GTP by GTP cyclohydrolase I isolated from E. coli [12] and immobilized on Sepharose 4-B. E. coli paste was obtained from Merck, (Darmstadt, FRG). Agarose/hexane/guanosine 5'-triphosphate (for purification of GTP cyclohydrolase I) and GTP lithium salt were from Sigma (St. Louis, USA). Tresyl-activated Sepharose 4-B (for immobilization of GTP cyclohydrolase I) and DEAESephadex A-50 were from Pharmacia Fine Chemicals (Uppsala, Sweden). Reduced sepiapterin was prepared enzymatically by reduction of sepiapterin with NADPH and bovine liver dihydrofolate reductase [29, 351. Dihydrofolate reductase was from Sigma. 6-( 1 '-Hydroxy-2'-oxopropyl)-5,6,7,8-tetrahydropterin was prepared by dehydrogenation of BH4 in the presence of NADP' and of sepiapterin reductase [28] . NADPH and NADP' were from Boehringer Mannheim. Ultrogel AcA 44 and AcA 34 were from LKB. Hydroxyapatite, silver-staining kit, and protein assay kit were from Bio-Rad. Fractogel TSK HW-5O(S) and DEAEFractogel 650 S were from Merck. Other chemicals were obtained from commercial sources.
Assay for PPH4S activity PPH4S activity was measured based on the observation that BH4 is produced from NHzTP by PPH4S and sepiapterin reductase in the presence of Mg2+ and NADPH [30, 33, 341 . The amount of BH4 produced was measured by HPLC with electrochemical detection [36] . The standard reaction mixture contained the following components: 100 mM Tris/HCl buffer, pH 7.4, 8 mM, MgCIz, 10 mM dithioerythritol, 32 pM, NHzTP, 1 mM, NADPH, about 2 mU sepiapterin reductase and the appropriate amount of PPH4S in a final volume of 125 pl. After incubation at 37°C for 60 min in the dark, the reaction was terminated by adding 25 pl 0.2 M EDTA, and 10 pl of the solution was injected into the HPLC system. One unit of PPH4S activity was defined as the amount which catalyzes the production of 1 pmol BH4/min under the above conditions.
For the determination of the pH optimum and the K , value of the enzyme, the above method is not suitable, since sepiapterin reductase activity also depends on the pH of the reaction mixture and on the concentration of its substrate, the intermediate PPH4. Therefore, the following assay method was developed, whch relies on the direct detection of PPH4 by HPLC with electrochemical detection [25] . In this case sepiapterin reductase and NADPH were omitted from the standard reaction mixture, an approximately twofold amount of PPH4S was used, and the incubation time was shortened to 30min. The relative amount of product produced was estimated from the peak area of the HPLC elution profile (cf. Fig. 8A ).
HPLC analysis of pterins
The HPLC conditions for analysis were essentially the same as described by Niedenvieser et al. [37] . HPLC was performed on a pre-column (4.6 x 40 mm) of Spherisorb S5 ODS reverse phase (Phase Sep, Holland) in series with an analytical column (4.9 x 250 mm) of Spherisorb ODSl (Kontron, Zurich, Switzerland), eluents consisting of: 6.6 mM Na2HPO4, 13.3 mM citric acid, 0.06 mM NazEDTA, 1.4 mM octane-sulfonic acid, 0.16 mM dithioerythritol and 10% methanol. Separation of reduced sepiapterin (6) from 6-(1'-hydroxy-2'-oxopropy1)-5,6,7,8 -tetrahydropterin (5) was achieved at a concentration of methanol of 5% [28] in the same system. The flow rate was 1 .O ml/min. The pterins were detected amperometrically at 250 mV by using an LC 4B amperometric detector with a TL 5A glassy carbon flow cell (Bioanalytical Systems, West Lafayette, IN, USA).
Miscellaneous methods
Protein concentration was measured with the Bio-Rad protein assay kit using bovine gamma globulin as a standard. The concentration of NH2TP was calculated from the molar absorption coefficient of dihydroneopterin, 6.2 mM-cm-' at 330 nm and pH 6.8 [38] .
Sepiapterin reductase was partially purified from human liver separated from PPH4S on a hydroxyapatite column [lo, 331, and it was concentrated with an Amicon PM-10 to a small volume and applied to an Ultrogel AcA 44 column. Active fractions from the Ultrogel column were again concentrated with Amicon PM-10 and dialyzed overnight against 0.02 M potassium phosphate buffer, ph 7.0 and stored at -70°C until use. Sepiapterin reductase activity was determined by the method of Katoh [39] .
Dihydropteridine reductase (EC 1.6.99.7) activity was measured by the method of Hasegawa [40] .
Electrophoresis on polyacrylamide gel was performed as described by Davis [41] . After electrophoresis, proteins on gel were visualized with the Bio-Rad silver stain kit. Localization of PPH4S on gel was determined by cutting slab gel of 1-mm thickness into pieces of 5-mm length, homogenization with 0.02 M potassium phosphate buffer, pH 7.0, centrifugation, and assay of the supernatant for enzyme activity. Electrophoresis on polyacrylamide gel in the presence of sodium dodecyl sulfate was performed as described by Laemmli [42] .
Determination of molecular mass
The molecular mass of the native enzyme was estimated by gel filtration as described by Andrews [43] using Ultrogel AcA 34, Ultrogel AcA 44 and Fractogel TSK HW-50 ( S ) as media. Columns of 1.6 x 90 cm were employed and they were equilibrated with 0.02 M potassium phosphate buffer, pH 1.0, containing 0.2 M KCl. A purified enzyme solution was applied to the columns. Fractions from the columns were assayed for enzyme activity. The following proteins were used as the standard markers: sweet potato jl-amylase (Mr 200000), yeast alcohol dehydrogenase (1 50000), pig heart diaphorase ( w l OOOOO), bovine serum albumin (66000), ovalbumin (45 000), bovine erythrocyte carbonic anhydrase (29000), equine skeletal muscle myoglobin (1 7 800), and horse heart cytochrome c (12400). Elution of the marker proteins was monitored by the absorbance at 280 nm.
RESULTS
Purification of PPH4S
PPH4S was purified from 500-g aliquots of human liver. All procedures were carried out at 4 "C unless otherwise specified.
Step 1. Crude extract. Human liver (250 g) was thawed and cut into small pieces and homogenized in a Virtis-45 homogenizer for 3 min with 2 vol. 0.01 M potassium phosphate buffer, pH 7.0 at half of full speed. The homogenate was blended with another portion of 2 vol. of the same buffer for an additional 3 min at two-thirds full speed and then it was centrifuged at 27000 x g for 60 min.
The resulting supernatant was filtered through cheesecloth to remove fat.
Step 2. Ammonium suvate fractionation. Solid ammonium sulfate was added to the supernatant to 35% saturation, the mixture was stirred for 40 min, the precipitate was removed by centrifugation at 11 000 x g for 60 min, and the supernatant was filtered again through cheesecloth to remove the last residues of fat. Additional solid ammonium sulfate was added to the resulting supernatant to 55% saturation. The mixture was stirred for 40min and the precipitate was collected by centrifugation at 11 000 x g for 60 min. The precipitated protein was dissolved with 80 ml of 0.01 M potassium phosphate buffer, pH 6.0, and dialyzed overnight against 10 1 of the same buffer. The dialyzed solution was stored at -20°C until used. The ammonium sulfate fraction was also prepared from another batch of 250 g human liver and the fractions from two batches were combined.
Step 3. Column chromatography on hydroxyapatite. The ammonium sulfate fractions obtained from two batches (i.e. starting from a total of 500g liver) were thawed and combined, and the solution was centrifuged at 27000 x g for 60min in order to remove precipitated protein. The supernatant solution was applied to a hydroxyapatite column ( 5 x 45 cm) that had been equilibrated with 0.01 M potassium phosphate buffer, pH 6 .0. After the column was washed with 300 ml of the buffer, the adsorbed proteins were eluted by a linear gradient with 1000 ml of 0.01 M potassium phosphate buffer, pH 6.0, in the mixing chamber and 1000 ml of 0.2 M potassium phosphate buffer, pH 6.0, in the reservoir. The flow rate was maintained at 80 ml/h and 20-ml fractions were collected. Sepiapterin reductase was retained on hydroxyapatite under the above condition; it was therefore also eluted with 0.3 M potassium phosphate buffer, pH 6.0, after collection of PPH4S. The elution profile is shown in Fig. 1 .
Step 4 . Heat treatment. Fractions from the hydroxyapatite column containing PPH4S activity were combined and concentrated with an Amicon PM-10 ultrafilter to about 50 ml. Since PPH4S is heat-stable [15, 26, 331, this solution was heated for 5 min at 80°C with gentle shaking in a water bath. The heat-treated suspension was cooled in an ice bath for 3 min, and centrifuged at 17000 x g for 30 min to remove denatured proteins.
Step 5. Gel filtration on Ultrogel AcA 44. The supernatant from the previous step was applied to an Ultrogel AcA 44 column (5 x 91 cm) equilibrated with 0.02 M potassium phosphate buffer, pH 7.0, containing 0.2 M KCl. The column was developed with the same buffer and 10-ml fractions were collected at a flow rate of 50 ml/h. The elution profile is shown in Fig. 2 . Active fractions were collected, combined, and concentrated by Amicon PM-10 ultrafiltration to about 8 ml and dialyzed overnight against 5 1 0.02 M potassium phosphate buffer, pH 7.0.
Step 6. Column chromatography on DEAE-Fractogel650 S. The solution obtained from the previous step was applied to a DEAE-Fractogel650 S column (2.6 x 34 cm) equilibrated with 0.02 M potassium phosphate buffer, pH 7.0. After washing with 80 ml of the same buffer, proteins were eluted with a linear gradient of 400 mlO.02 M potassium phosphate buffer, pH 7.0, in the mixing chamber and 400 ml of the same buffer containing 0.4 M KCl in the reservoir. Each 10-ml fraction was collected at a flow rate of 40 ml/h. The elution profile is shown in Fig. 3 . Active fractions were collected and combined. The combined solution was concentrated by Amicon PM-10 ultrafiltration into a small volume and dialyzed overnight against 5 1 0.01 M potassium phosphate buffer, pH 7.0. Table 1 presents a summary of a typical p d i c a t i o n of PPH4S from 500 g human liver. By this procedure the enzyme was purified approximately 140000-fold with an overall recovery of about 60%. The purification of PPH4S by this procedure has been repeated four times and the protein elution profiles from the various columns are completely reproducible; however, the purification factor and the overall recovery varied in the ranges of 40000-150000 and 33 -61 YO, respectively, depending on the batches of liver used.
The enzyme was not homogeneous at this level of purification. When the purified enzyme was subjected to electrophoresis on polyacrylamide gel, one major protein band and two minor bands were observed (Fig. 4A) . When proteins were extracted from polyacrylamide gel after electrophoresis and subjected to enzyme assay, PPH4S activity corresponded very well to the main protein band. Proteins corresponding to other minor bands did not affect BH4 formation. In order to obtain PPH4S of apparent homogeneity, PPH,S from the DEAE-Fractogel purification step was subjected to preparative polyacrylamide gel electrophoresis using a 1-mm-thick slab gel. Electrophoresis of the material obtained was homogeneous (Fig. 4B ). This homogeneous preparation of the enzyme was concentrated again by Amicon PM-10 ultrafiltration ( x 0.2 mg/150 pl); it can be stored at -70°C for several months without appreciable loss of activity. The results to be presented in the following sections of this paper were obtained with this homogeneous enzyme preparation.
Properties of the enzyme
The enzymatic synthesis of BH4 (7) from NHzTP ( I ) (cf. Scheme 1) was found to be linear with time up to at least Fig. 4 One unit of activity is defined as the amount of enzyme which catalyzes the production of 1 pmole BH4/min from NHzTP at 37 "C under standard assay conditions. The activity of the crude extract was measured in the absence of dithioerythritol with an enzyme preparation which was heat-treated at 80°C for 5 min; without heating, activity decreased to 35%, and about 55% of NHzTP was converted to dihydroneopterin by phosphatases during the incubation; in the presence of 10 mM dithioerythritol activity decreased to 50 -70%. The activity of the ammonium sulfate fraction was measured with enzyme heat-treated at 80°C for 5 min; without heating, activity decreased to 45%, and about 60% of NHzTP was converted to dihydroneopterin by phosphatases formation. The standard reaction mixtures, containing various amounts of dithioerythritol or mercaptoethanol, were incubated for 60 min at 37°C with 9 pU PPH4S. Aliquots of 10 p1 from the incubated mixtures were injected into the HPLC system and the amount of BH4 produced was measured. ( 0 ) Amount of BH4 produced in the presence of dithioerythritol (DTE); (0) amount of BH4 produced in the presence of mercaptoethanol 60 min of incubation when an excess of sepiapterin reductase was used in the standard reaction mixture. Sepiapterin reductase, NADPH, and MgZf, as well as PPH4S, were essential for BH4 (7) production from NHzTP (I); if one of these components was omitted from the standard reaction mixture, BH4 formation did not occur at all. Using pure PPH4S, BH4 formation was increased in the presence of dithioerythritol as shown in Fig. 5 . However, when a rather crude preparation of the enzyme was used for this experiment, enhancement of BH4 formation was not observed; on the contrary, the activity of PPH4S in crude extracts was decreased by 30 -50% by the addition of 10 mM dithioerythritol. For this reason PPH4S activity was measured in the absence of dithioerythritol during the early step of purification. A 20-min pre-incubation of PPH4S with 1 mM dithioerythritol, followed by incubation in the presence of 2% of this concentration, i.e. 0.02 mM, led to an increased activity comparable to that shown in Fig. 5 . The effect of dithioerythritol on pure enzyme probably resides in the reduction of (essential) disulfide bridges of PPH4S; the effect observed with crude extracts, however, is as yet unexplained. The enzymatic productibn of PPH4 (4) from NHzTP (I) in the presence of Mg2+ and PPH4S was linear with time up to at least 30 min of incubation under anaerobic conditions. In the absence of Mg2+ no PPH4 (4) was produced. The activity optimum of the enzyme was pH 7.5 in Tris/HCl buffer as shown in Fig. 6 . It is apparent from the dependencies shown in Fig. 6 , that the nature of the buffer as well as its ionization state play an important role in catalysis. The effects observed might also originate from interactions of buffers such as Tris or imidazole with Mg2+. PPH4 formation from NHzTP exhibited typical Michaelis-Menten kinetics.
The K, value for NHzTP was estimated to be 10 pM from a double-reciprocal plot [44] as shown in Fig. 7 .
The molecular mass of the enzyme was estimated to be about 83 kDa from the elution volume using three different gel filtration columns, AcA 34, AcA 44, and Fractogel TSK HW-50 (S), which were calibrated with standard proteins. The results obtained by use of the three different media gave approximately the same value of the molecular mass of PPH4S. When the purified enzyme was subjected to electrophoresis on polyacrylamide gel containing sodium dodecyl sulfate, a single band with an estimated molecular mass of When NH2TP (I) was incubated with PPH4S in the presence of Mg2+ under anaerobic conditions, it was converted to a compound which is detectable electrochemically under conditions which are specific for tetrahydropterins [36] as shown in Fig. 8A . This compound has been proposed to be PPH4 (4) , which is supposed to be unstable; its structure is shown in Scheme 1 [22, 24-26] . NADPH was not required for this transformation, confirming previous results [24] . It has been proposed [22, 311 that the catalytic action of PPH4S involves the conversion of a dihydropterin chromophore, which is characterized by an absorption maximum at 330 nm in the near-ultraviolet, to a tetrahydrochromophore. The latter does not exhibit prominent absorption in this region, thus allowing a spectroscopic monitoring of the process. Switchenko et al. [22] have indeed shown, that partially purified preparations from D . melanogaster induce changes in the spectrum of NH2TP which are consistent with the proposed change of the redox status. Essentially the same conversion was obtained using our pure PPH4S as shown in Fig. 9 .
Clearly, the conversions shown are compatible with the disappearance of the dihydropteridine chromophore. Although the general pattern of the conversion is similar to that observed by Switchenko et al. [22] , some differences are also apparent. In our case, a compound with a pronounced maximum just above 300 nm is formed after 1 h of incubation. This is consistent with formation of a tetrahydropterin chromophore since the latter has a A,,, around 300 nm (e.g. BH4, A, , , = 297 nm [45] ). The minor difference in A, , , can arise from the different side chain at position 6 and also from the presence of enzyme in our incubation mixture. During the first 50% of the conversion there appears to be only marginal absorption in the 380-450 nm region. This again contrasts with the formation of a maximum at 400 nm observed with the Drosophila system [22] . It is not clear that a structure such as that of PPH4 (4) should have such an absorbance which is typical of 1'-0x0-dihydropterins such as sepiapterin, since the triaminopyrimidine chromophore is electronically separated from the side-chain carbonyl groups. The appearance of this (Fig. 9) . It is thus probable that it originates from decay products of PPH4. Analysis of the incubation mixture obtained after 60min with HPLC indicates complete disappearance of NH2TP and formation of PPH4.
Investigations of the conversion of PPH4 (4) to BH4 (7) are hampered by the lability of the former. They were thus carried out.with material generated by incubation of NH2TP with PPH4 without isolation. This was done by addition of EDTA to the incubation mixture, which stops the activity of PPH4S by complexation of Mg2 + .
Several experiments were carried out with PPH4 generated by t h s method. Subsequent addition of sepiapterin reductase and NADPH to this reaction mixture (cf. legend to Fig. 8 for details), leads to formation of BH4 (7) (Fig. SC) . Qualitatively the same result was obtained using PPH4 (4) which was purified by HPLC, as will be detailed elsewhere (Leimbacher, W. and Curtius, H.-Ch., unpublished work). The same secondary incubation of PPH4 with sepiapterin reductase and NADPH was also carried out in the presence of N-acetylserotonin, a potent inhibitor of sepiapterin reductase [46] . In this case (Fig. 8B) , PPH4 (4) was converted to a compound having a retention time coinciding with that of 6-(1 '-hydroxy-2'-oxopropyl)-5,6,7,8-tetrahydropterin (5) [28] . This contrasts with experiments in which PPH4 (4) was incubated with crude homogenate of human liver (purification step 2) instead of partially purified sepiapterin reductase. In this case the reaction in the presence of N-acetylserotonin gave a different compound, the retention time of which coincided with that of 6-(~-lactoyl)-5,6,7,8-tetrahydropterin (1, 6 'dihydro-sepiapterin'). When N-acetylserotonin was omitted, BH4 (7) formation was observed as usual.
The sepiapterin reductase used for the conversions of PPH4 was obtained after Ultrogel AcA 44 filtration; it was not homogeneous according to polyacrylamide gel electro-phoresis. Attempts to purify sepiapterin reductase further by use of DEAE-Sephadex A-50 (pH 7.0), did not yield a homogeneous protein; however, when this sepiapterin reductase preparation was used for the incubation of PPH4 (4), the amount of BH4 (7) produced was strongly decreased although not suppressed, in spite of using the same amount of sepiapterin reductase activity determined by measuring the reduction rate of sepiapterin [39] . This indicates the presence of a further enzyme, which is not essential for production of BH4 (3, but which clearly plays a catalytic role. Indeed, as will be detailed later (Takikawa, S., Heintel, D., Curtius, H.-Ch., unpublished work) further purification of fractions eluting from the hydroxyapatite column has led to isolation of an enzyme which has no sepiapterin reductase activity and is not inhibited by N-acetylserotonin. Incubation of PPH4 (4) with this enzyme in the presence of NADPH leads to formation of 6-lactoyl-5,6,7,8-tetrahydropterin (6), while no further product was observed (cf. Scheme 1). A further factor affecting the yield of BH4 (7) was the presence of considerable amounts of dihydropteridine reductase activity in preparations of sepiapterin reductase obtained from the DEAESephadex A-50 column. Dihydropteridine reductase has been reported to be necessary to optimize formation of BH4 in in vitro systems [30] . This indicates, that during these incubations partial oxidation of PPH4 or of subsequent intermediates to the corresponding quinonoid dihydropterin forms occurs, and that the latter can be reconverted to the tetrahydro level by dihydropteridine reductase. Therefore, for general assays in which formation of BH4 (7) is monitored, the use of partially purified sepiapterin reductase at the Ultrogel AcA 44 purification level (which contained a substantial amount of dihydropteridine reductase activity) proved to be optimal.
DISCUSSION
The results presented in this paper indicate that PPH4S is a single protein which catalyzes two reactions, that is, elimination of phosphate from NHzTP ( I ) [33] and an internal oxidoreduction leading to PPH4 (4) (Scheme 1). The enzyme consists of four identical subunits of 19 kDa each, the molecular mass of tetrameric PPH4S being 83 kDa. This value is higher than the 63 kDa reported in earlier papers [lo, 28, 331. However, we think that the higher value is more accurate, because it was obtained by analysis of the homogeneous protein and was measured by using three different media for gel filtration. PPH4S was clearly eluted from these three different columns earlier than bovine serum albumin, which has a molecular mass of 66 kDa. The value of 83 kDa also agrees well with the value of 82 kDa reported for the same enzyme from D. rnelanogaster [14] .
Total activity, purification factor and recovery (presented in Table 1 ) sometimes varied depending on the different batches of human liver used. In addition to the origin of the liver, the quality of the enzymatically prepared NH,TP, which was used for the assays, was also found to affect formation of BH4. Traces of dihydropteridine reductase, which are contained in the sepiapterin reductase used for the assays and which were found to increase the yield of BH4, appear to be of practical importance. The role of this enzyme is assumed to consist in the reduction of pteridines which have been oxidized non-enzymatically to the quinonoid dihydro form by 0, during the assay, to the tetrahydro level [l, 301. On the other hand, the finding that high concentrations of dithioerythritol lower BH4 yields when crude liver extracts With respect to the mechanisms of the conversion of NH2TP (1) to PPH4 (4) , it appears clear that the homogeneous enzyme can catalyze the two necessary steps [47] with equal efficacy since the conversion appears to proceed isosbestically (Fig. 9 ) [22] and since intermediates such as 1, 2 or 3 (Scheme 1) have never been observed by us or by others. The experimental determination of the sequence of these two steps, i.e. elimination of triphosphate [33] and the internal oxidoreduction, might prove very difficult to achieve. It is conceivable that the same enzyme base which is assumed to induce triphosphate elimination by abstracting the 2'-hydrogen as a proton might be positioned to remove also the 1'-H (as a proton) and thus to catalyze also the internal redox shuttle (Scheme 1). The assumed intermediates 2 or 3 might thus not leave the enzyme active center during catalysis, resulting in a direct conversion of NH2TP (1) to PPH4 (4) . From a chemical point of view [47] , a prediction is difficult. Elimination of phosphate from I will yield the dihydropterin 3 in which the 1'-hydrogen should be considerably more acidic. The same, however, holds for 2, in which the 2'-hydrogen should also be more acidic, as compared to 2'-H in 1. In any event, from these considerations it is reasonable to assume that the 'second step' in the conversion of I to 4 might be faster than the first one. This would agree with the observation of no intermediates mentioned above.
In contrast to this, for the conversion of PPH4 (4) to BH4 (7) a clear-cut picture begins to emerge. Our results are in good agreement in particular with those of Masada et al. [30] , which were obtained with homogeneous sepiapterin reductase and which showed that this single enzyme is competent in the conversion of PPH4 (4) to BH4 (3, although at a slow rate.
From our results it appears that a further enzyme is present in human liver, which converts PPH4 (4) to 6-lactoyltetrahydropterin (6) (Scheme 1) in the presence of NADPH, but apparently not further to BH4 (7). This enzyme might be tentatively named 6-pyruvoyl-tetrahydropterin-2'-reductase ('PPH4R) (Scheme 1). Sepiapterin reductase catalyzes the conversion of 5 to BH4 (7), as has been shown using purified 5, or by demonstration of dehydrogenation of BH4 (7) to 5 in the presence of NADP' [28, 481. On the other hand, sepiapterin reductase also efficiently reduces 6 to BH4 (7) [21, 22, 25, 491 . The elucidation of details concerning the conversion of PPH4 (4) to BH4 (7) will have to await the purification of the presumed PPH4 reductase to homogeneity, the study of its reaction kinetics with isolated 4 , 5 and 6, and the comparison of these properties with those of pure sepiapterin reductase in the presence and absence of Nacetylserotonin. It thus appears conceivable that both pathways (i.e. lower right-hand side proceeding over intermediate 6, or lower left-hand side over 5, Scheme 1) might be viable depending on the specific conditions and also on the properties of these two enzymes which might differ depending on the sources. The effects on N-acetylserotonin on the conversions induced by sepiapterin reductase are not yet clear, although they suggest that reduction of 1 '-and 2'-carbonyl groups are inhibited to different degrees.
